LIVDELZI

seladepar lysine · Gilead Sciences, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LIVDELZI, covering 2024-08-14 to 2026-01-30. Get the full timeline:

Most recent: FDA Approved: LIVDELZI — Supplemental Application (Gilead Sciences, Inc)